Vitaeris
Website: www.vitaerisbio.com
Address:
1500-355 Burrard Street
Vancouver, BC V6C 2G8
Phone: +1 (844) 448-2580
Email (Business Development): bd@vitaerisbio.com
Member Sector: Biopharmaceuticals
Vitaeris is a clinical stage biopharmaceutical company dedicated to the development of a novel investigational approach to address antibody mediated rejection. Antibody mediated rejection has been recognized as the principal cause of late graft loss in solid organ transplant recipients. Our focus is on Clazakizumab, a potent humanized best-in-class monoclonal antibody targeting the cytokine interleukin-6 (IL-6)